{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:21:42Z","timestamp":1778620902180,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC1501"],"award-info":[{"award-number":["2022NSFSC1501"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC0728"],"award-info":[{"award-number":["2022NSFSC0728"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2021YJ0126"],"award-info":[{"award-number":["2021YJ0126"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871300"],"award-info":[{"award-number":["81871300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["2024kjTzn04"],"award-info":[{"award-number":["2024kjTzn04"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["CMC-XK-2103"],"award-info":[{"award-number":["CMC-XK-2103"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112597","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T20:43:01Z","timestamp":1719866581000},"page":"112597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["VX-509 (Decernotinib)-modified tolerogenic dendritic cells alleviate experimental autoimmune neuritis by promoting Th17\/Treg rebalance"],"prefix":"10.1016","volume":"138","author":[{"given":"Juan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yantang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112597_b0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ajem.2023.11.031","article-title":"Further considerations regarding Guillain-Barre syndrome","volume":"76","author":"Madden","year":"2024","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.intimp.2024.112597_b0010","doi-asserted-by":"crossref","unstructured":"2023. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barre Syndrome. Neurology 101:592.","DOI":"10.1212\/WNL.0000000000207874"},{"key":"10.1016\/j.intimp.2024.112597_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-023-06916-6","article-title":"Autoreactive T cells target peripheral nerves in Guillain-Barre syndrome","author":"Sukenikova","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112597_b0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jocn.2020.03.010","article-title":"Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barre Syndrome","volume":"75","author":"Debnath","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.intimp.2024.112597_b0025","doi-asserted-by":"crossref","first-page":"e01478","DOI":"10.1002\/brb3.1478","article-title":"Th17 cells and their cytokines serve as potential therapeutic target in experimental autoimmune neuritis","volume":"9","author":"Liu","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.intimp.2024.112597_b0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cei\/uxac084","article-title":"The potential for treg-enhancing therapies in nervous system pathologies","volume":"211","author":"Olson","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2024.112597_b0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41577-021-00615-x","article-title":"The conventional dendritic cell lineage is born","volume":"21","author":"Guilliams","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"eabm0631","key":"10.1016\/j.intimp.2024.112597_b0040","article-title":"Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function","volume":"7","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.intimp.2024.112597_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733231","article-title":"Transcriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature","volume":"12","author":"Robertson","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2024.112597_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168415","article-title":"Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity","volume":"22","author":"Passeri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.intimp.2024.112597_b0055","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.1900552","article-title":"Tolerogenic Dendritic Cells Generated by BAFF Silencing Ameliorate Collagen-Induced Arthritis by Modulating the Th17\/Regulatory T Cell Balance","volume":"204","author":"Zhao","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2024.112597_b0060","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3389\/fphar.2019.01579","article-title":"Regulatory Dendritic Cells Induced by K313 Display Anti-Inflammatory Properties and Ameliorate Experimental Autoimmune Encephalitis in Mice","volume":"10","author":"Zhou","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.intimp.2024.112597_b0065","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1136\/annrheumdis-2015-208901","article-title":"Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings","volume":"75","author":"Genovese","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2024.112597_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106318","article-title":"Topical VX-509 attenuates psoriatic inflammation through the STAT3\/FABP5 pathway in keratinocytes","volume":"182","author":"Yan","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.intimp.2024.112597_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154686","article-title":"The pivotal role of JAK\/STAT and IRS\/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids","volume":"112","author":"Kooshki","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.112597_b0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1046\/j.1600-6143.2003.00225.x","article-title":"Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3","volume":"3","author":"Saemann","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.intimp.2024.112597_b0085","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1136\/annrheumdis-2013-203756","article-title":"The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells","volume":"73","author":"Kubo","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2024.112597_b0090","doi-asserted-by":"crossref","first-page":"5021537","DOI":"10.1155\/2016\/5021537","article-title":"Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17\/Treg Balance","volume":"2016","author":"Zhou","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.intimp.2024.112597_b0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jnr.23357","article-title":"Curcumin ameliorates rat experimental autoimmune neuritis","volume":"92","author":"Han","year":"2014","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.intimp.2024.112597_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111489","article-title":"Ginsenoside Rd attenuates mouse experimental autoimmune neuritis by modulating monocyte subsets conversion","volume":"138","author":"Ren","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.intimp.2024.112597_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-9167-9_4","article-title":"Bone Marrow-Derived Dendritic Cells","volume":"1960","author":"Roney","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.intimp.2024.112597_b0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7862-5_19","article-title":"Myelin Protein Zero(180\u2013199) Peptide Induced Experimental Autoimmune Neuritis in C57BL\/6 Mice","volume":"1791","author":"Gonsalvez","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.intimp.2024.112597_b0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/1097-4547(20001201)62:5<717::AID-JNR11>3.0.CO;2-P","article-title":"P0 protein peptide 180\u2013199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL\/6 mice","volume":"62","author":"Zou","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.intimp.2024.112597_b0120","doi-asserted-by":"crossref","unstructured":"Hartung, H. P., Sch\u00e4fer, B., Heininger, K., Stoll, G., and Toyka, K. V. 1988. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations. Brain 111 (Pt 5):1039.","DOI":"10.1093\/brain\/111.5.1039"},{"key":"10.1016\/j.intimp.2024.112597_b0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/jns.12412","article-title":"Incidence and mortality rates of Guillain-Barre syndrome in Serbia","volume":"25","author":"Stojanov","year":"2020","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.intimp.2024.112597_b0130","first-page":"23:48","article-title":"B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1","author":"Shi","year":"2023","journal-title":"BMC Neurol"},{"key":"10.1016\/j.intimp.2024.112597_b0135","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.4049\/jimmunol.1302254","article-title":"An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-\/- mice results in attenuated disease","volume":"192","author":"Ray","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2024.112597_b0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12974-023-02822-w","article-title":"Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis","volume":"20","author":"Kohle","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.intimp.2024.112597_b0145","doi-asserted-by":"crossref","first-page":"1038411","DOI":"10.3389\/fimmu.2022.1038411","article-title":"Sex differences in Guillain Barre syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis","volume":"13","author":"McCombe","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2024.112597_b0150","doi-asserted-by":"crossref","first-page":"1198327","DOI":"10.3389\/fnins.2023.1198327","article-title":"COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy","volume":"17","author":"Gomez","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.intimp.2024.112597_b0155","first-page":"2568","article-title":"Immunotherapy of Guillain-Barre syndrome","volume":"14","author":"Liu","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.intimp.2024.112597_b0160","first-page":"1145","article-title":"Effect of Toll-like receptor 4 deficiency on clinical severity and expression of Th1\/Th2\/Th17-associated cytokines in a murine model of experimental autoimmune neuritis","volume":"19","author":"Wang","year":"2023","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.intimp.2024.112597_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577186","article-title":"Autoantigen specific IL-2 activated CD4(+)CD25(+)T regulatory cells inhibit induction of experimental autoimmune neuritis","volume":"341","author":"Tran","year":"2020","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2024.112597_b0170","doi-asserted-by":"crossref","first-page":"e13024","DOI":"10.1111\/cpr.13024","article-title":"Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barre syndrome","volume":"54","author":"Li","year":"2021","journal-title":"Cell Prolif"},{"key":"10.1016\/j.intimp.2024.112597_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577042","article-title":"Intravenous immunoglobulin promotes the proliferation of CD4(+)CD25(+) Foxp3(+) regulatory T cells and the cytokines secretion in patients with Guillain-Barre syndrome in vitro","volume":"336","author":"Zhang","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.intimp.2024.112597_b0180","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.39473","article-title":"VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis","volume":"68","author":"Genovese","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.intimp.2024.112597_b0185","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.38949","article-title":"A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis","volume":"67","author":"Fleischmann","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.intimp.2024.112597_b0190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.intimp.2024.112597_b0195","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrd.2017.267","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"17","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.intimp.2024.112597_b0200","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood-2013-03-484642","article-title":"The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo","volume":"122","author":"Heine","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2024.112597_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.750346","article-title":"Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors","volume":"12","author":"Cattaneo","year":"2021","journal-title":"Front Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:57:12Z","timestamp":1778619432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924011184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":41,"alternative-id":["S1567576924011184"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112597","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VX-509 (Decernotinib)-modified tolerogenic dendritic cells alleviate experimental autoimmune neuritis by promoting Th17\/Treg rebalance","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112597"}}